Integrating Graph Convolution and Attention Mechanism for Kinase Inhibition Prediction

Kinase is an enzyme responsible for cell signaling and other complex processes. Mutations or changes in kinase can cause cancer and other diseases in humans, including leukemia, neuroblastomas, glioblastomas, and more. Considering these concerns, inhibiting overexpressed or dysregulated kinases through small drug molecules is very important. In the past, many machine learning and deep learning approaches have been used to inhibit unregulated kinase enzymes. In this work, we employ a Graph Neural Network (GNN) to predict the inhibition activities of kinases. A separate Graph Convolution Network (GCN) and combined Graph Convolution and Graph Attention Network (GCNGAT) are developed and trained on two large datasets (Kinase Datasets 1 and 2) consisting of small drug molecules against the targeted kinase using 10-fold cross-validation. Furthermore, a wide range of molecules are used as independent datasets on which the performance of the models is evaluated. On both independent kinase datasets, our model combining GCN and GAT provides the best evaluation and outperforms previous models in terms of accuracy, Matthews Correlation Coefficient (MCC), sensitivity, specificity, and precision. On the independent Kinase Dataset 1, the values of accuracy, MCC, sensitivity, specificity, and precision are 0. 96, 0. 89, 0. 90, 0. 98, and 0. 91, respectively. Similarly, the performance of our model combining GCN and GAT on the independent Kinase Dataset 2 is 0. 97, 0. 90, 0. 91, 0. 99, and 0. 92 in terms of accuracy, MCC, sensitivity, specificity, and precision, respectively.